1 Followers on Owler

Handl Therapeutics

is a biotechnology company that develops and commercializes gene therapies for the treatment of neurodegenerative diseases... Read more
OverviewCompetitorsNews & Insights

Handl Therapeutics

is a biotechnology company that develops and commercializes gene therapies for the treatment of neurodegenerative diseases... Read more
Handl Therapeutics Co-Founder & CEO: Florent Gros

Co-Founder & CEO

Florent Gros

CEO Approval Rating

90/100

2019

PrivateSubsidiary of UCB S.A.

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?

News

Nov 12, 2020
PharmaTimes
Handl Therapeutics: UCB acquires gene therapy specialist Handl Therapeutics
Nov 02, 2020
The Pharma Letter
Handl Therapeutics: BRIEF-Novasep and Handl sign gene therapy product development and manufacturing deal

Handl Therapeutics Competitors

1BrainVectis
2Spark Therapeutics
3Prevail Therapeutics
Unlock more competitors

Trending Companies